Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Pfizer’s new RA treatment shows promise

November 11, 2009 Research and Development, Sales and Marketing Pfizer, RA

 Pfizer has announced data from two clinical studies of its developmental rheumatoid arthritis candidate.CP-690550 is the first in a new …
News
We the people

Vote brings US health reform closer

November 10, 2009 Sales and Marketing Obama, US, US healthcare, reform

Momentus reform of America’s healthcare system is a step closer following the passing of a bill in the House of …
News

Think tank ranks NHS highly

November 9, 2009 Sales and Marketing NHS

 The Department of Health has taken the opportunity to blow its own trumpet by publicising a US think tank’s report …
News

Novartis gets German OK for swine flu vaccine

November 5, 2009 Research and Development, Sales and Marketing Novartis, h1n1

 Novartis’ swine flu vaccine Celtura has been approved in Germany, its first market, in what is a major milestone for …
News

New Merck & Co opens for business

November 5, 2009 Sales and Marketing MA, Merck, restructure

The new corporate entity formed by the Merck & Co/Schering-Plough merger has at last opened its doors for business.The Schering-Plough …
News
Actelion Robin

Actelion UK appoints Robin Bhattacherjee General Manager

November 4, 2009 Research and Development, Sales and Marketing Actelion, appointment, research and development, sales and marketing

Actelion UK has appointed Robin Bhattacherjee general manager for the UK and Ireland. He will be based at the company’s …
Appointment

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009 Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …
News

Phase III success for GSK’s lupus drug

November 3, 2009 Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …
News

GSK-Genmab blood cancer drug approved in US

November 2, 2009 Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …
News
Synovate Jackie

Jackie Ilacqua, head of oncology, Synovate

November 2, 2009 Sales and Marketing appointment, sales and marketing, synovate

Synovate has appointed Jackie Ilacqua to the newly-created role of head of oncology.Formerly responsible for building and managing Synovate’s global …
Appointment

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009 Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …
News

GSK returns to growth despite US sales hit

October 28, 2009 Sales and Marketing GSK, generics

GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …
News

GSK begins phase III COPD trials

October 28, 2009 Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
News
Tarceva tablets

Comparing notes: UK’s cancer leaders discuss the latest advances

October 28, 2009 Research and Development, Sales and Marketing Cancer

 
Feature

Merck KGaA’s rising revenues fail to lift bottom line

October 27, 2009 Sales and Marketing Merck Serono

 Revenues up, earnings down: that was the bottom line to Merck KGaA’s financial performance in the three months to the …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026